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ABSTRACT
Comparative mutagenesis of 1,N
6-ethenoadenine
(eA) and 8-oxoguanine (8-oxoG), two endogenous
DNA lesions that are also formed by exogenous DNA
damaging agents, have been evaluated in HeLa
and xeroderma pigmentosum variant (XPV) cell
extracts. Two-dimensional gel electrophoresis of
the duplex M13mp2SV vector containing these
lesions established that there was significant inhibi-
tion of replication fork movement past eA, whereas
8-oxoG caused only minor stalling of fork progres-
sion. In extracts of HeLa cells, eA was weakly
mutagenic inducing all three base substitutions
in approximately equal frequency, whereas 8-oxoG
was 10-fold more mutagenic inducing primarily G!T
transversions. These data suggest that 8-oxoG is a
miscoding lesion that presents a minimal, if any,
block to DNA replication in human cells. We hypo-
thesized that bypass of eA proceeded principally by
an error-free mechanism in which the undamaged
strand was used as a template, since this lesion
strongly blocked fork progression. To examine this,
we determined the sequence of replication products
derived from templates in which a G was placed
across from the eA. Consistent with our hypothesis,
93% of the progeny were derived from replication
of the undamaged strand. When translesion synth-
esis occurred, eA!T mutations increased 3-fold
in products derived from the mismatched eA: G
construct compared with those derived from the eA:
T construct. More efficient repair of eA in the eA: T
construct may have been responsible for lower
mutation frequency. Primer extension studies with
purified pol g have shown that this polymerase is
highly error-prone when bypassing eA. To examine if
pol g is the primary mutagenic translesion polymer-
ase in human cells, we determined the lesion bypass
characteristics of extracts derived from XPV cells,
which lack this polymerase. The eA: T construct
induced eA!G and eA!C mutant frequencies that
were approximately the same as those observed
using the HeLa extracts. However, eA!T events
were increased 5-fold relative to HeLa extracts.
These data support a model in which pol g-mediated
translesion synthesis past this adduct is error-free in
the context of semiconservative replication in the
presence of fidelity factors such as PCNA.
INTRODUCTION
1,N
6-Ethenoadenine (eA) and 8-oxoguanine (8-oxoG) are
DNA lesions induced both by endogenous and exogenous
agents. eA is formed by a metabolite of the human
carcinogen vinyl chloride and various other vinyl com-
pounds (1). It is also formed by lipid peroxidation, which
generates several a, b-unsaturated carbonyl compounds
(2,3). The level of eA detected in human liver is usually
low ( 20 lesions per 10
9 dA) (4), but it increases
signiﬁcantly as a result of enhanced lipid peroxidation in
patients with genetic metal storage disorders such as
Wilson’s disease and primary hemochromatosis (5).
Diet also inﬂuences the level of eA. The mean level of
eA is 40-times higher in women who consume diets high
in linoleic acid compared with those on high oleic acid
diets (6).
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pairing region, but syn rotation of the base allows
Hoogsteen-type base pairing (7,8). Early studies on
in vitro translesion synthesis across eA indicated that
misincorporation may depend on the DNA polymerase
used (9,10) and that G incorporation opposite eA occurs
more frequently. More recent studies with the Y family
polymerases showed that translesion synthesis past eAi s
100-fold more eﬃcient with human pol Z compared to
pol k, although signiﬁcant base substitutions and one-base
deletions occurred with each of these two polymerases
(11). Misincorporation of all three nucleotides was also
observed in cells. However, eA is only weakly mutagenic
in Escherichia coli (12,13). In contrast, in single-stranded
(ss) DNA, eA is highly mutagenic in simian kidney cells,
inducing primarily eA!G transitions (13). Analysis of
the sequence of duplex plasmids with a single lesion
replicated in human cells indicates that only about 10%
of the progeny reﬂected replication using the strand that
contained the eA. In these cases, replication proceeds by
translesion synthesis (TLS) mechanisms, which is pre-
dominantly error-free; however, all three nucleotide
changes have also been detected in 7–14% of the TLS
progeny (14). In most cases, replication proceeds using the
undamaged strand as the template, suggesting that eAi sa
block to DNA replication (14). eA is a substrate for
alkylpurine DNA-N glycosylase, and homologs of this
enzyme have been found in E. coli, Saccharomyces
cerevisiae, rat and human cells (15,16).
8-OxoG is a ubiquitous oxidative lesion in DNA formed
by exogenous agents such as ionizing radiation (17).
It is also formed during endogenous metabolic processes
(18). Mutagenicity of 8-oxo-dG determined in a number
of studies in E. coli and in mammalian cells showed that it
predominantly induces G!T transversions (19–21). The
mutation frequency (MF) of a single 8-oxo-dG is in the
range of 3–8% in ss DNA in both bacterial and
mammalian cells (reviewed in 22), though higher MF in
a speciﬁc sequence was noted (23). In double-stranded
(ds) DNA the MF is much lower (24), presumably due
to a more eﬃcient repair. Multiple repair systems have
evolved to repair this damage (see 25,26 for reviews).
8-Oxoguanine DNA glycosylase, the product of mutM,
also known as Fpg protein, in bacteria and its eukaryotic
functional homolog, the Ogg1 protein, eﬃciently repairs
8-oxoG opposite cytosine. For 8-oxoG: A pairs, the MYH
(MUTYH), a mammalian homolog of bacterial MutY
protein, acts as the adenine DNA glycosylase (27). The
importance of oxidative damage repair was underscored in
a study (28), which demonstrated that inherited variants
of the human homolog of mutY, MYH, is associated with
somatic G: C!T: A mutations in colorectal cancer.
Irrespective of how mutagenic a lesion might be in ss
DNA, because of a more eﬃcient repair, mutagenicity of
the lesion is drastically reduced in duplex DNA. In
addition, stalling (or blockage) of replication at the lesion
site often result in a strand-bias of replication, such that a
major fraction of the progeny arises from the undamaged
strand. We wished to evaluate the mutational types and
frequencies of these two important lesions in extracts of
human cells without any strand maker such as a mismatch
or reporter sequence, which might trigger some unusual
biological response. Since translesion synthesis across
these two lesions by pol Z has been reported (11,29), we
also compared the mutagenicity of eA and 8-oxoG in
extracts of xeroderma pigmentosum variant (XPV) cells,
which are defective in this DNA polymerase.
MATERIALS AND METHODS
Materials
[g-
32P]ATP was from Du Pont New England Nuclear
(Boston, MA, USA). T4 DNA ligase and T4 polynucleo-
tide kinase were obtained from New England Bioloabs
(Beverly, MA, USA). The replication template M13mp2-
SVoriL, E. coli strains NR9162 (mutS), CSH50 and
NR9099 were gifts from Dr Thomas Kunkel, National
Institute of Environmental Health Sciences, NIH.
Methods
Synthesis and characterization of oligonucleotides. The 26
mer oligonucleotides, 50CGG CCA GTG CC(eA)
TCG CTA CCA ATT CG-30,5 0-CGG CCA GTG CCA
TCG
8-oxo CTA CCA ATT CG-30,were synthesized by the
Midland Certiﬁed Reagent Company, Inc (Midland, TX,
USA). The deprotection of eA 26-mer was carried out in
the presence of 1,8-diazabicyclo[5.4.0]undec-7-ene as
described (30). The 8-oxoG oligonucleotide was depro-
tected with concentrated NH4OH for 18h at 558C in the
presence of 0.25M b-mercaptoethanol. The oligonucleo-
tides were puriﬁed by HPLC followed by denaturing
polyacrylamide gel electrophoresis. Mass spectrometric
analysis by MALDI-TOF veriﬁed the molecular weight of
the oligonucleotides.
Construction of M13 vectors containing a single eAo r
8-oxoG. The 26 mer oligonucleotide (48pmol) containing
the lesion was phosphorylated using 1.5U of T4
polynucleotide kinase (10U/ml) and 0.5mlo f1 0 m M
ATP in 70mM Tris–HCl, 10mM MgCl2, 5mM dithio-
threitol, pH=7.6at 378C for 30min. The enzyme was
inactivated at 658C for 20min. The phosphorylated
primer was annealed to the ss M13mp2SV DNA template
(6pmol) in 20mM Tris–HCl, pH=7.4, 2mM MgCl2,
50mM NaCl by heating at 708C for 5min, followed by
cooling down to room temperature over a period of 2h.
The annealed primer was extended by adding 45U of T4
DNA polymerase (3U/ml) and 2ml 50% glycerol in 20mM
Tris-HCl, pH=7.4, 2mM dithiothreitol, 10mM MgCl2,
0.5mM dNTP’s and 0.4mM ATP at the following
conditions: incubation in ice for 10min, room temperature
for 5min and at 378C for 1.5h. The nick on the newly
synthesized strand was ligated using 400U of T4 DNA
Ligase (400U/ml) at 158C overnight. Following inactiva-
tion of the enzymes at 658C for 20min, methylation of
the newly synthesized strand was carried out by adding
32U of dam Methylase (8U/ml) and 0.8mlo f3 2 m M
S-adenosylmethionine in 50mM Tris–HCl, 10mM
EDTA, 5mM 2-mercaptoethanol, pH=7.5at 378C for
1h. The veriﬁcation of successful methylation was
performed by treating 1mg of each construct with 1U
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acetate, 10mM magnesium acetate, 1mM dithiothreitol,
pH=7.9at 378C for 1h. Samples (0.5mg each) of the ss
DNA template, ds M13mp2SV40, unmethylated con-
struct, methylated construct, DpnI-treated unmethylated
and methylated constructs are run in 0.8% agarose gel in
1  TAE Buﬀer for 2.5h at 48C. Replicative form I (RF I)
DNA was obtained by puriﬁcation on two CsCl gradients
according to published procedures (31,32).
Cell lines, culture conditions and preparation of cell
extracts. Skin ﬁbroblasts derived from xeroderma pig-
mentosum variant patient XP115Lo were immortalized
with hTERT and were obtained from Dr Lisa McDaniels
(University of Texas Southwestern Medical School,
Dallas, TX, USA) under the terms of MTA 3025 between
WGM and Geron Corporation. Cells were cultured under
standard conditions in DMEM, 10%FCS and antibiotics.
HeLa cells were cultured under the same conditions, in
DMEM supplemented with 10% SCS and antibiotics.
Replication-competent cell extracts were prepared by
hypotonic nuclear extraction according to the method of
Li and Kelly (33), as described (31,32).
Two-dimensional (2D) gel electrophoresis. Replication
fork movement past the lesion site was determined by a
modiﬁcation of the method of Brewer and Fangman
(34,35). Replication reactions were performed as described
but stopped after 30min. The products were puriﬁed
and digested with the indicated restriction enzyme(s).
Electrophoresis in the ﬁrst dimension was carried out
at 0.4V/cm for 68h in 0.4% agarose gels containing
0.2mg/ml ethidium bromide, prepared with TBE buﬀer.
The lanes were excised and cast into a second gel that was
1% agarose in TBE buﬀer containing 0.2mg/ml ethidium
bromide. The second dimension was carried out at
908 with respect to the ﬁrst, and electrophoresis continued
at 1.5V/cm for 24h. The gels were dried and exposed to
phosphor screens and scanned with a Typhoon
PhosphorImager.
Analysis of the scanned images was carried out using
the polygon tool and ImageQuant. Only replication-
intermediate arcs were quantiﬁed, using volume integra-
tion with no background subtraction. The intensity of
bubble and fork arcs were expressed as percentages of the
sum of all replicating structures detected.
Replication and analyses. Reactions, carried out as
described previously (31), contained 40ng of the template
in a total volume of 25ml. T antigen was omitted from the
control reaction tubes. Following addition of replication-
competent cell extract (75–100mg of protein), the reaction
mixtures were incubated for 1h at 378C. An aliquot
(1/10 volume) was taken for determination of [a-
32P]dCTP
incorporation into acid-insoluble material. An internal
standard consisting of pUC19 restricted with HindIII and
end-labeled with
32P was added to each sample. The DNA
was extracted and treated with DpnI to digest any fully
methylated (i.e. unreplicated) templates. Aliquots of the
samples were electrophoresed on 1% agarose gels contain-
ing 0.5mg/ml ethidium bromide. The density of the bands
corresponding to covalently closed circular (form I) DNA
was quantiﬁed by use of ImageQuant software in a
Molecular Dynamics PhosphorImager. The amount of
form I synthesis as a percentage of synthesis of DNA from
the control (undamaged) template was corrected for loss
of the DNA during the puriﬁcation procedure by normal-
izing the density of the form I band to that of the internal
control.
An aliquot of the puriﬁed, newly replicated DNA was
electroporated into E. coli strain NR9162, which is
deﬁcient in mismatch repair (mutS) to avoid correction
of heteroduplex DNA. Immediately after electroporation,
these bacteria were coplated with an indicator strain,
E. coli CSH50. The transfected bacteria replicate the
bacteriophage and infect the surrounding indicator
bacteria, resulting in colorless plaques in the lawn of
indicator bacteria. The assay scores only newly replicated,
covalently closed circular DNA molecules. After over-
night incubation at 378C, the plates were overlaid with
nylon membranes (Boehringer Mannheim) and the
plaques were screened for mutations in the region of the
lesion by hybridization. Since the MF for eA was low, we
used both mutant probe and wild-type probe to detect
mutations, and all putative mutants were sequenced.
For 8-oxoG, preliminary analysis showed that only
8-oxoG!T mutations occurred at a signiﬁcant level.
The only other type of mutant detected was 8-oxoG!C,
which occurred at level of 5–10% of the G!T events.
We therefore concentrated in determining only the
8-oxoG!T mutations.
RESULTS AND DISCUSSION
Construction of M13mp2SVoriLvectors
The template was derived from M13mp2SVoriL (36),
which contains the SV40 origin of replication and will
undergo semiconservative bidirectional replication in the
presence of SV40 large T antigen and replication-
competent extracts derived from human cells. A +11
mutant clone of M13mp2SVoriL was generated by
inserting d(GGTAGCGATGG) into the EcoRI site of
the multiple cloning region of the bacteriophage (Figure 1)
(32). As shown in Scheme 1, an unmodiﬁed or modiﬁed
50-phosphorylated 26mer oligonucleotide was annealed
to the ss M13 DNA, and the primer was extended
with T4 DNA polymerase and deoxynucleotide triphos-
phates. Ligation was carried out with T4 DNA ligase
and the duplex DNA was methylated with dam methylase.
Progress in each step was analyzed by agarose
gel electrophoresis. Figure 2 shows the ss M13 DNA
(lane 1) on which the eA 26-mer was annealed. Lanes 3
and 4 show the extended and ligated DNA before and
after methylation, respectively. Lane 5 shows the DpnI-
digested construct, which completely eliminated the faster
running form I DNA. The form I DNA was puriﬁed by
cesium chloride density gradient centrifugation in the
presence of ethidium bromide. The latter was removed
by ion-exchange chromatography, phenol-chloroform
extraction and ethanol precipitation. The ﬁnal yield of
covalently closed circular (form I) DNA was 8–10%.
1302 Nucleic Acids Research, 2008, Vol. 36, No. 4Results from the 8-oxoG, unmodiﬁed constructs, and the
mismatched constructs were also similar (data not shown).
Replication forkmovement past thelesion site
To determine the extent of replication fork blockage by eA
or 8-oxoG, we examined the topology of DNA replication
intermediates by 2D gel electrophoresis. This technique
has proven to be useful for characterizing origins of
replication (34,35). The properties of bubble arcs and
single fork arcs in such gels have been characterized
(37,38), and the technique has provided insights into
replication fork bypass of a T–T cyclobutane pyrimidine
dimer in the leading strand template (39).
The progression of the replication fork up to and
beyond the lesion was examined by digesting the replica-
ted molecules with ClaI, which cuts M13mp2+11 760
bases to the right of either adduct and  1808 away from
the SV40ori (Figure 1). This results in two linear
fragments of 4.3 and 3.1kb. The larger fragment contains
the SV40ori located asymmetrically (Figure 3A), and 2D
gel electrophoresis of replicated undamaged templates
revealed two families of DNA replication intermediates
associated with the 4.3kb fragment with diﬀerent topol-
ogies (Figure 3A and B). These include structures with a
bubble arc and those with a single fork arc. The bubble arc
structures represent intermediates that have not yet
progressed beyond the ClaI site closest to the ori, and
single forks result when replication has proceeded beyond
this site. Such progression resulted in the appearance of
single fork arcs associated with the 3.1kb fragment.
Analysis of the replication intermediates derived from
templates containing eA (Figure 3C) or 8-oxoG
(Figure 3D) clearly show that single fork arcs are
associated with the 4.3kb fragment. This implies that
the right fork has passed the ClaI site at position 7043 and
can therefore be inferred to have bypassed the lesion in the
leading strand template. Although it is formally possible
that the right fork is completely blocked and the left fork
proceeds all the way around to replicate past both
restriction sites, previous studies have shown that this
does not happen during the short incubation times used in
these experiments (39). Examination of the gels indicates
replication intermediates that correspond to the 7.4kb
template, indicated by the open triangles in Figure 3B–D.
Figure 1. Construction of M13mp2-SV +11 with a single ethenoade-
nine or 8-oxoguanine adduct. The ethenoadenine was placed in position
6284, indicated by A
  in the diagram. The 8-oxoguanine was placed in
position 6287, but is not indicated in the diagram for clarity.
Semiconservative bidirectional replication proceeds from the center of
the SV40 ori, such that the right fork traverses only  300 bases before
it encounters the lesion. Therefore, the lesions are presumed to be in the
leading strand template. Control templates did not contain DNA
damage, and mismatched templates contained a guanine residue
opposite the lesion. The ClaI restriction sites used in the 2D gel
electrophoresis analysis of the replication products are also indicated.
12345
III −
Form I −
ss − 
II −
Figure 2. Agarose gel electrophoresis of M13mp2SVoriL +11 construct
containing eA. Lane 1: ss M13mp2SV; Lane 2: ds M13mp2SV
standard; Lanes 3 and 4, respectively, represent the eA construct
following primer extension (and ligation) before and after treatment
with dam methylase; Lane 5 shows the material from lane 4 after DpnI
digestion.
1. Annealing
2. Extension
3. Ligation
T4 DNA ligase
T4 DNA Polymerase 
dNTP′s
 4. Methylation
dam Methylase 
 5. CsCl density- 
gradient purification
26-mer primer 
(phosphorylate
d at the 5′ end
ss M13 DNA
M13 construct
Scheme 1. General protocol for making the M13mp2SVoriL +11
construct.
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they have incorporated the radioactive dCTP precursor
and do not appear if T-antigen is omitted from the
reaction (data not shown). These large structures have
been interpreted to be replication intermediates in which
the right fork has been stalled by the lesion in the leading
strand template, but downstream priming on the lagging
strand template continues for some distance. This ‘fork
uncoupling’ results in a single-strand region in the leading
strand template, which is not subject to cutting by ClaI.
This interpretation was originally proposed by Cordiero-
Stone and colleagues (39) to explain similar structures
observed when a T–T cyclobutane pyrimidine dimer was
placed in the leading strand template. As diagrammed in
Figure 4, A represents initiation of replication around the
SV40 ori and B, fork progression in templates that do not
contain a lesion. Coordinate leading and lagging strand
synthesis continues past the ClaI site and the resulting
double-strand regions are subject to cutting by the
restriction enzyme. In the case of a replication-blocking
lesion in the leading strand template (Figure 4C and D),
synthesis of the nascent strand using that template is
blocked. However, replication using the lagging strand
template may continue downstream for some distance.
This results in a population of large intermediates that
are not cut by the enzyme. The magnitude of this arc
relative to the other replication intermediates is a measure
of the degree of inhibition of fork progression. This high
molecular weight intermediate is clearly most pronounced
when the template containing the eA is replicated
(Figure 3C), indicating that this lesion blocks replication
to a greater extent than the 8-oxoG (Figure 3D).
Quantitation of the relative intensities of these arcs
indicates that 8-oxoG increases the intensity of this arc
1.6-fold over the control template, compared with 6-fold
for eA. These results support the conclusion that eAi n
the leading strand template represents a signiﬁcant block
Figure 4. Proposed replication intermediates. The template used in these studies is a7.4kbp plasmid that contains the SV40 origin of replication (ori). The
helicase activity of large T antigen allows assembly of DNA replication forks and subsequent bidirectional replication that proceeds from the ori. Panels
(A) and (B) represent initiation and progression of fork movement when there is no impediment to fork progression. The two ClaI sites (shown in
Figure 1) remain principally in double-stranded regions. Most of the replication intermediates are cut by the restriction enzyme, such that there is very
little of the full-length intermediate denoted by the open triangles in Figure 3B and D. Panels (C) and (D) illustrate blockage of the right leading strand
replication complex by eA with progression of replication of the lagging strand (fork uncoupling). Replication of the lagging strand has been estimated
to proceed for  700 bases in this system when the leading strand is blocked by a lesion in that template (39). The resulting single-stranded region is not cut
by ClaI, and this is reﬂected by an increased intensity in the large intermediate denoted by the open triangle in Figure 3C.
Figure 3. 2D gel electrophoresis of replication intermediates digested
with ClaI. Extracts from HeLa cells were incubated for 30min in the
presence of T-antigen with control DNA (A and B) or DNA containing
a single ethenoadenine (C) or 8-oxoguanine (D), as described in
Materials and Methods section. The puriﬁed DNA was digested with
ClaI and separated by 2D gel electrophoresis. The positions of the
linear 4.3 and 3.1kb fragments are indicated in panel A, together with
the replication intermediates associated with these fragments. SF arc
means single fork arc, whereas bubble arc indicates the replication
forks that had not yet reached the ClaI sites. The arcs indicated by the
open triangles in panels B, C and D are discussed in the text.
1304 Nucleic Acids Research, 2008, Vol. 36, No. 4to fork progression, while 8-oxoG constitutes only a
minor impediment.
Mutagenicity ofeAand 8-oxoG in extracts of human cells
As expected, in the absence of a strand-marker most of the
progeny from the adducted vector contained no muta-
tions. In order to collect all possible mutational events, we
screened the progeny derived from the eA template with
all possible base pair mutant probes and the non-mutant
or wild-type probe. Our analysis using a combination of
oligonucleotide hybridization and DNA sequencing indi-
cated that small frameshifts (additions or deletions) did
not occur during replication of any of these constructs.
For eA all three base substitutions occurred with
approximately equal frequency in HeLa cells, but the
level of mutagenesis was low (total MF  7 10
 4)
(Table 1). In contrast, 8-oxoG, however, induced G!T
transversions at a 10-fold higher level (MF 69 10
 4)
(Table 1 and Figure 5). We hypothesized that the low
frequency of mutations induced by eA is a reﬂection of the
strong block to replication that this adduct presents.
In this case, replication can be completed by error-free
template switching mechanisms or potentially error-prone
translesion synthesis. To examine this, we assessed the
fraction of progeny derived from these to two mechanisms
using a strand marker. We made two constructs in which
eA or A in the ( ) strand was placed opposite G in the
(+) strand. Approximately 60% progeny derived from the
unmodiﬁed A:G mismatched construct contained a G in
the (+) strand (Table 2). In contrast,  93% progeny in
the eA:G construct contained a G in the (+) strand
(Table 2). This is consistent with eA being a strong block
of replication, with replication proceeding by copying the
information in the undamaged strand (i.e. template
switching). In the mismatched construct, it is noteworthy
that the eA!T mutations increased 3-fold to 10 10
 4
(Table 2), in comparison to the eA: T construct that
produced 3 10
 4 eA!T. If  7% progeny came from the
eA-containing strand, the calculated eA!T mutations
derived from the lesion containing strand of the eA: T and
eA: G construct, respectively, were 0.4 and 1.4%, which
reﬂects a low error rate during translesion synthesis and/or
eﬃcient repair. One explanation for the 3-fold increased
mutagenesis from the mismatched construct is a less
eﬃcient repair in the eA: G construct. Similar experiments
with 8-oxoG mismatched with G showed that compared
with 54% from the control G: G construct, 70% progeny
from the 8-oxoG: G construct contained a G in the (+)
strand (Table 3). Therefore, 30% progeny was derived
from TLS of 8-oxoG in the ( ) strand relative to 46% in
the control, which suggests that 8-oxoG stalled but did
not provide a major block of replication as we noted
in our fork progression study. It is noteworthy that the
8-oxoG!T transversions increased nearly 7-fold to 4.8%
(Table 3). Therefore, we conclude that 8-oxoG repair in
8-oxoG: G mismatch, similar to eA:G, is ineﬃcient in
HeLa extract.
It is important to consider if abasic sites formed by
excision of the lesions by a glycosylase were responsible
for the mutations observed in our study. We believe it
unlikely because earlier studies have shown that most
( 85%) TLS events involve insertion of dAMP opposite a
synthetic abasic site in several human cell lines (40),
whereas we noted a very diﬀerent signature of eA-induced
mutations in this study. Evidently, this argument
cannot be used for 8-oxoG because dAMP insertion is
the predominant misincorporation event opposite both
8-oxoG and abasic site. However, in an in vitro study
it was shown that in HeLa cell extracts eA is repaired
Table 1. Mutagenicity of eA and 8-oxoG in extracts of HeLa and XPV cells
Cell nine Lesion Total plaques analyzed Type of Mutation Mutation frequency (  10
 4)
!C !G !T
HeLa eA 12782 2 – – 1.6
eA 10486 – – 3 2.9
eA 15351 – 3 – 2.0
G
8-oxo (un) 19551 ND ND 180 92
G
8-oxo 14606 ND ND 101 69
XPV eA 13158 2 – – 1.5
eA 12475 – – 18 14.4
eA 17749 – 2 – 1.1
G
8-oxo (un) 17039 ND ND 149 88
G
8-oxo 18922 ND ND 106 56
ND, not determined; G
8-oxo (un) indicates construct that was not methylated with dam methylase.
Figure 5. Mutational frequency ( 10
 4)o feA and 8-oxoG in HeLa
(dark bars) and XPV (gray bars) extracts.
Nucleic Acids Research, 2008, Vol. 36, No. 4 1305by both short and long patch repair, whereas 8-oxoG is
repaired mainly by the short patch pathway (41). This
investigation also demonstrated that the repair kinetics of
8-oxoG is much slower than that of a preformed abasic
site, which also suggests that the 8-oxoG!T mutations in
our study were unlikely to be derived from abasic sites.
In a prior study, Moriya and coworkers found eAt ob e
mutagenic in human cells with MF between 7 and 14% in
duplex DNA after the progeny from the undamaged
strand was eliminated (14). Furthermore, in this study in
comparison to 8-oxoG, eA was found to be much more
mutagenic (14). Our data is in stark contrast to this study,
and we found 8-oxoG to be more mutagenic than eA. We
believe that the primary reason for this diﬀerence stems
from the diﬀerence between the two experimental systems.
The sequence contexts used in these two studies were
diﬀerent. More importantly, in the Levine et al. (14) study
eA was incorporated opposite a guanine and the two bases
adjacent to the lesion also contained mismatches, which
would generate a small bubble. eA opposite guanine
rotates to syn and this mismatched region might have
resulted in a less eﬃcient repair. In contrast, in the M13
vector we used, the lesion was located in a perfectly
complementary region opposite thymine, which probably
triggered a more eﬃcient repair. We investigated this
possibility by incorporating eA opposite G and, consistent
with our hypothesis, the eA!T substitutions increased
3-fold. In vitro repair studies showed that eA opposite T or
C is excised at a comparable rate (42), but the kinetics of
repair opposite G or in a mismatched bubble have not
been determined.
Published reports of primer extension assays using
puriﬁed polymerases to synthesize past eA or 8-oxoG
adducts in the templates indicate that pol Z bypasses
8-oxoG eﬃciently and accurately (29), whereas it bypasses
eA in an error-prone manner (11). If these results reﬂect
the function in pol Z in vivo, then the absence of this
enzyme might result in enhanced mutagenesis of 8-oxoG
and reduced mutagenesis of eA. Therefore, we examined
mutational consequence of these two lesions in XPV cells,
which do not have functional pol Z. To our surprise, we
found that eA!T mutations increased 5-fold in extracts
of XPV cells, whereas the eA!C and eA!G substitu-
tions remained approximately the same. Furthermore, the
frequency of 8-oxoG!T mutations was 20% lower (MF
56 10
 4) when the modiﬁed templates were replicated
with extracts from XPV cells relative to those replicated
with extracts from HeLa cells. The helix-distorting lesions
that block replication fork progression are now known to
require the Y family polymerases for TLS. This has been
most intensively studied for pol Z, and it is generally
accepted that a principal role of this polymerase is to
synthesize past UV-induced cyclobutane pyrimidine
dimers in an error-free manner (43). However, its role,
if any, in mutagenic TLS past other damages is much less
certain.
Since the frequency of 8-oxoG!T mutations did not
change in the absence of pol Z, it can be inferred that
this enzyme is not principally involved in TLS past such
adducts in human cells. It is also possible that another
Y-family enzyme with similar bypass characteristics
assumes its function. Since these miscoding lesions do
not present a signiﬁcant block to DNA replication, one
might speculate that the replication complex synthesizes
past them with minimal requirements for Y-family
polymerases. In yeast, however, pol Z seems to play a
critical role in the error-free bypass of 8-oxoG, whereas
pol d stalls at both insertion and extension steps (29).
For the mutagenic bypass of 8-oxoG, it was suggested
that either pol Z or pol  can extend from the dAMP
incorporated opposite 8-oxoG by pol d, but pol  is likely
to be more eﬀective at this step since it is nearly as eﬃcient
at extending from the A opposite 8-oxoG as it is in
extending C opposite G, whereas pol Z extends from an A
opposite 8-oxoG with an  6-fold reduced eﬃciency (44).
Our result in XPV extract suggests that pol  might play
the role of extender of A opposite 8-oxoG rather than pol
Z, but another polymerase must have successfully replaced
Table 2. Replication of eA:G and A:G constructs in extracts of HeLa cells
a
M13 construct Progeny containing a G Progeny containing a T
(arising from the
A-containing ( ) strand)
eA!T mutants
A:G 1353 of 2232 (61%) 991 of 2323 (43%) N/A
eA:G 1710 of 1836 (93%) 188 of 2052 (9%) 16 of 15965 (0.1% overall
but 1.4% from eA strand)
b
aThe constructs contained a G in the (+) strand and an eA or A opposite it in the ( ) strand.
bThe percent eA!T from eA strand was calculated on the basis of 7% (or 1118) plaques arising from the strand containing eA.
Table 3. Replication of 8-oxoG:G and G:G constructs in extracts of HeLa cells
a
M13 construct Progeny containing a G 8-oxoG!T mutants
G:G 708 of 1321 (54%) N/A
8-oxoG:G 1291 of 1840 (70%) 455 of 9501 (4.8% overall but 16.0% from 8-oxoG strand)
b
aThe constructs contained a G in the (+) strand and an 8-oxoG or G opposite it in the ( ) strand.
bThe percent 8-oxoG!T from 8-oxoG strand was calculated on the basis of 30% (or 2850) plaques arising from the strand containing 8-oxoG.
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high degree of evolutionary conservation of the mecha-
nism of TLS in yeast and human cells, whether the human
DNA polymerases behave similarly toward 8-oxoG
remains to be investigated. It is noteworthy that human
polymerase k also is eﬃcient in extending from the
nucleotides incorporated opposite 8-oxoG by pol d (45).
It should be reiterated, however, that despite facile bypass
of 8-oxoG by these puriﬁed specialized DNA polymerases,
their role in a cell is not clear at this time.
In this context, it is intriguing to note that the absence
of pol Z resulted in a 5-fold increase in eA!T
substitutions, not a decrease as predicted by the primer
extension data quoted above. Pol Z is known to require
PCNA for optimal activity (46,47), and the data in the
current study support a role for this enzyme in error-free
TLS of eA adducts. In the absence of pol Z, another
Y-family polymerase presumably assumes its function in a
manner analogous to the error-prone TLS activity of pol i
past UV photoproducts (48,49). Although TLS is the
source of virtually all mutations induced by replication-
blocking lesions, the overwhelmingly preferred mode of
resolution of blocked replication forks is recombination.
This is supported by the ﬁnding in the current study that
most progeny phage derived from templates that con-
tained an eA resulted from preferential copying of the
undamaged strand. This method of lesion bypass pre-
sumably proceeds by fork uncoupling and template-
switching mechanisms.
In conclusion, in duplex DNA eA was a strong block to
replication fork progression but was weakly mutagenic in
HeLa cell extracts, inducing all three base substitutions
in approximately equal frequency. In contrast, 8-oxoG
presented a weak block to fork progression but was
10-fold more mutagenic inducing primarily G!T trans-
versions. In XPV cells, mutagenicity of 8-oxoG was only
slightly lower, while eA!T substitutions increased 5-fold.
These data support a model in which the replication-
blocking lesion eA requires a Y-family polymerase for
TLS, which may be pol Z acting in an error-free manner.
In contrast, 8-oxoG lesions do not present a signiﬁcant
block to fork progression. Instead, in most cases the
replication complex itself correctly interprets the altered
base as ‘G’. Rarely, mutations may be generated when the
lesion is misinterpreted as ‘T’. Although data indicate that
pol d is not very eﬃcient in bypassing 8-oxoG, recent
evidence implicates pol e in replication of the leading
strand template (50). To our knowledge, the lesion bypass
characteristics of this enzyme have not been studied. In
either case, our data support a model in which 8-oxoG
presents a minimal block to fork progression. In this case,
the principal mode of bypass may be the replication fork
itself, with the specialized DNA polymerases playing a
secondary role.
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